Shares of Regeneron Pharmaceuticals Inc. slid 4.67% to $567.89 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.55% to 6,656.92 ...

Pharmaceutical innovation saves lives. But not every "new" drug is truly new. Subscribe to our newsletter for the latest ...

McKesson on Tuesday raised its profit forecast, as the U.S. drug distributor aims to focus on high-margin businesses such as ...

By extending their monopoly on a drug, companies prevent generics and other competitors from driving down prices. But increasing transparency can help prevent Big Pharma from gaming the patent system.

In the assessment of 12-month price targets, analysts unveil insights for Ionis Pharmaceuticals, presenting an average target ...